Sysmex Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx Premium Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area. Qiagen, Sysmex Form Global Companion Diagnostic Development Pact The companies will develop and commercialize liquid biopsy CDx assays using Sysmex's Plasma-Safe-SeqS next-generation sequencing technology. Sysmex Obtains Japan Marketing Approval for Use of Saliva With Coronavirus Kit To enable the use of saliva in addition to other types of samples, Sysmex requested a change to a marketing approval it obtained in March. Sysmex Partec to Distribute De Novo Flow Cytometry Software Worldwide By running FCS Express on the CyFlow Cube V2m device, Sysmex Parec believes customers will benefit from an analysis software that allows advanced reporting capabilities and data export options. Sysmex Obtains Japan Marketing Approval to Distribute BGI Genomics Coronavirus Kit Sysmex anticipates delivering the kit to Japanese medical institutions this month for diagnosis of the SARS-CoV-2 infection. Feb 11, 2020 Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics Premium Jan 22, 2020 Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent Nov 26, 2019 Biolidics, Sysmex Partner on Cancer Liquid Biopsy Development Nov 1, 2019 Sysmex, Optim to Establish Digital Medicine Joint Venture Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Aug 2, 2019 Sysmex Gets Japanese Manufacturing, Marketing Approval for Colorectal Cancer Screening Assay Nov 28, 2018 Sysmex, MolecularMD to Collaborate for CDx Development, Commercialization Sep 28, 2018 New Products Posted to GenomeWeb: Roche, Sysmex Inostics, Mawi DNA Technologies, More Nov 14, 2017 Genedrive, Sysmex Sign Asia Pacific Distribution Agreement for HCV Test Oct 16, 2017 Genedrive, Sysmex Europe Sign EMEA Distribution Agreement for HCV Test, MDx Platform Jul 27, 2017 BioMérieux, Sysmex Dissolve Japanese Joint Venture May 31, 2017 Sysmex to Acquire Oxford Gene Technology May 20, 2016 In Brief This Week: Qiagen; DiaSorin; Quest; Agilent; Thermo Fisher Scientific; and More Apr 15, 2016 Expansion of Liquid Biopsy Test Sites Planned by Merck KGaA, Sysmex Premium Apr 7, 2016 Merck KGaA, Sysmex Inostics Garner CE Mark for Liquid Biopsy CRC Test Mar 28, 2016 Sysmex, Clearbridge BioMedics to Partner on CTC Liquid Biopsy System Feb 29, 2016 Sysmex Inks Global Deal with Streck Feb 16, 2016 Eisai, Sysmex to Develop Dx, CDx for Dementia Jun 1, 2015 Sysmex, LabCorp Collaborate on Blood Testing for Personalized Medicine Apr 22, 2015 Sysmex Inostics Inks OncoBEAM Distribution Deal with IndivuTest Load More Breaking News Bio-Rad Laboratories, Cytek Biosciences Partner on Flow Cytometry Reagents Tecan Inks Deals for NGS Library Prep System With Element Biosciences, Singular Genomics Genomenon, Flagship Biosciences Partner on Biomarker Discovery, Companion Dx Development Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform Evonetix Raises $24M in Extended Series B Funding Round The Scan Study Points to Tuberculosis Protection by Gaucher Disease Mutation A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds. SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource. Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages. UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.